Author: Site Editor Publish Time: 2025-11-07 Origin: Site
ENO Partners with Taiji Mianyang Pharmaceutical to Set a New Benchmark for Intelligent Vehicle Operation and Maintenance in the Pharmaceutical Industry
—Enabling Efficient Travel and Safety Management for Enterprises with Integrated Parts and Service Solutions
[September 2025]
Amid the accelerated digital and intelligent transformation of the pharmaceutical industry, the safe operation and efficient dispatch of enterprise vehicles are becoming crucial components in supporting production and operations. Recently, our company ,ENO (Haikou) Technology Co., Ltd., successfully partnered with Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. ("Taiji Mianyang Pharmaceutical") to provide them with an integrated intelligent vehicle solution encompassing parts supply, installation and commissioning, platform services, and after-sales support.
Taiji Mianyang Pharmaceutical, a well-known company in the pharmaceutical industry, owns a comprehensive fleet of 50 vans, 20 Coasters, 15 Jinbei vehicles, 10 buses, and 30 commercial vehicles, forming a large and comprehensive corporate vehicle system. These vehicles perform core functions such as pharmaceutical logistics and transportation, employee commuting, and business reception, serving as the "mobile lifeline" that ensures the efficient operation of the company's production and operations.
Taiji Mianyang Pharmaceutical has differentiated requirements for parts procurement and intelligent management based on the operational needs of different vehicle types. Vans require traceability and safety assurance, while passenger vehicles like Coasters, buses, and commercial vehicles prioritize driver safety monitoring, stable equipment operation, and a comfortable experience.
Our company provides customized intelligent monitoring and parts solutions for their Buick, Chery, Jinbei, Coaster, King Long, and Mianyang Yutong vehicles. Our products cover core modules such as vehicle safety monitoring, data storage, signal transmission, and platform services. We precisely match these solutions to the specific operating characteristics of each vehicle to ensure system reliability and adaptability.
This partnership not only marks our company's successful entry into the pharmaceutical vehicle aftermarket but also further validates our technical strength in multi-scenario intelligent monitoring and operation and maintenance services. Going forward, our company will continue to provide more comprehensive parts upgrades and service support for all Taiji Mianyang Pharmaceutical vehicles, helping them reduce vehicle operating costs, improve transportation and commuting efficiency, and set a new benchmark for smart mobility in the pharmaceutical industry.
